´ëÇÑÁ¶Çöº´ÇÐȸ Overcoming the common Difficulties in Schizophrenia Clinic : 2019-11-08±³À°ÀÏÀÚ : 2019-11-08
±³À°Àå¼Ò : °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ
±³À°ÁÖÁ¦ :
Overcoming the common Difficulties in Schizophrenia ClinicÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÁ¶Çöº´ÇÐȸ
´ã´çÀÚ : ÀÌÈ£¼±
¿¬¶ôó : 02-552-6677
À̸ÞÀÏ :
lhs510@hanmail.net ±³À°Á¾·ù : Á¤½Å°Ç°ÀÇÇаú
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í - »çÀüµî·Ï: Æò»ýȸ¿ø ¸éÁ¦ / Àü¹®ÀÇ, ±³¼ö(PhD) 50,000 / Àü°øÀÇ ¹× ±ºÀü¹®ÀÇ, ÀÏ¹Ý 30,000 / Á¤½Å°Ç°°ü·Ã ±Ù¹«ÀÚ¡¤´ëÇлý¡¤´ëÇпø»ý 20,000 - ÇöÀåµî·Ï: Á¤È¸¿ø ¸éÁ¦ / Àü¹®ÀÇ, ±³¼ö(PhD) 60,000 / Àü°øÀÇ ¹× ±ºÀü¹®ÀÇ, ÀÏ¹Ý 40,000 / Á¤½Å°Ç°°ü·Ã ±Ù¹«ÀÚ¡¤´ëÇлý¡¤´ëÇпø»ý 30,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 09:50~11:05 Very late-onset schizophrenia-like psychosis ÀÌÁß¼±(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 11:05~11:20 how to deal with clinical high risk (CHR) individulas ÀÌÅ¿µ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 11:20~11:30 Dopamine supersensitivety psychosis: a cause of treatment resistant schizophrenia ±èÀÇÅÂ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 11:30~11:40 Pseudo-resistant schizophrenia due to non-adherence À̽ÂÀç(°æºÏÀÇ´ë)
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 11:40~11:50 Lauguage processing brain and its associations with verbal ability and positive symptoms in first-onset psychosis ¹æ¹ÎÁö(Â÷ÀÇÀü¿ø)
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 14:00~14:30 Antipsychotiocs-induced obsessive-compulsive symptoms ÀÌÁØÈñ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 14:30~14:50 tardive movement disorders ÀÌÁ¤¼®(±¹¹Î°Ç°º¸ÇèÀϻ꺴¿ø)
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 14:50~15:10 Hyperprolactinemia and related hormonal disturbances À̺ÐÈñ(¸¶À½°ú¸¶À» Á¤½Å°Ç°ÀÇÇаúÀÇ¿ø)
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 15:10~15:30 Antipsychotics-induced restless legs syndrome °½Â°É(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 15:40~16:00 Á¶Çöº´ ³«Àΰú Á¤½ÅÀǷἺñ½º ÀÌ¿ë ÀÌÀ¯»ó(¿ëÀκ´¿ø)
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 16:00~16:30 Á¤½Å°Ç° °ü·Ã ÀÏ°£Áö ±â»ç ºÐ¼®[¿¬±¸±â±Ý ¼öÇý°úÁ¦] À¯½ÂÇü(Àü³²ÀÇ´ë)
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 16:30~17:00 ´ëÁ߸ÅüÀÇ Á¶Çöº´ ³«ÀÎ ½ÇÅÂ¿Í ±Øº¹ ±è¼º¿Ï(Àü³²ÀÇ´ë)
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 17:00~17:20 ¾ð·Ð ÀÔÀå¿¡¼ º» Á¶Çöº´ ±Ç´ëÀÍ(Çѱ¹ÀϺ¸)
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 09:50~11:50 Talking about voices: How to structure a helpful conversation Mark Hayward(University of Sussex, UK)
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 14:00~14:20 Clinical features and prevalence of metabolic syndrome in schizophrenia ÇѱԸ¸(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 14:20~14:40 Biological mechanisms of metabolic syndrome in schizophrenia ±è¼¼Çö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 14:40~15:00 Pharmacological management of metabolic syndrome in schizophrenia À̽ÂÀº(µ¿±¹ÀÇ´ë ³»°ú)
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 15:00~15:30 Non-pharmacological management of metabolic syndromen in schizophrenia °½ÃÇö(±¹¸³Á¤½Å°Ç°¼¾ÅÍ)